(2R,3S)-2-hydroxy-3-(1H-indol-3-yl)butanoic acid

Details

Top
Internal ID a62127d6-e351-417e-8e1e-5f5d5eef3954
Taxonomy Organoheterocyclic compounds > Indoles and derivatives > Indoles > 3-alkylindoles
IUPAC Name (2R,3S)-2-hydroxy-3-(1H-indol-3-yl)butanoic acid
SMILES (Canonical) CC(C1=CNC2=CC=CC=C21)C(C(=O)O)O
SMILES (Isomeric) C[C@@H](C1=CNC2=CC=CC=C21)[C@H](C(=O)O)O
InChI InChI=1S/C12H13NO3/c1-7(11(14)12(15)16)9-6-13-10-5-3-2-4-8(9)10/h2-7,11,13-14H,1H3,(H,15,16)/t7-,11+/m0/s1
InChI Key NUFXPJOTSOMKFZ-WRWORJQWSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C12H13NO3
Molecular Weight 219.24 g/mol
Exact Mass 219.08954328 g/mol
Topological Polar Surface Area (TPSA) 73.30 Ų
XlogP 1.60
Atomic LogP (AlogP) 1.72
H-Bond Acceptor 2
H-Bond Donor 3
Rotatable Bonds 3

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (2R,3S)-2-hydroxy-3-(1H-indol-3-yl)butanoic acid

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9945 99.45%
Caco-2 - 0.5395 53.95%
Blood Brain Barrier + 0.6250 62.50%
Human oral bioavailability + 0.6714 67.14%
Subcellular localzation Mitochondria 0.5421 54.21%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9420 94.20%
OATP1B3 inhibitior + 0.9518 95.18%
MATE1 inhibitior - 0.9400 94.00%
OCT2 inhibitior - 1.0000 100.00%
BSEP inhibitior - 0.7876 78.76%
P-glycoprotein inhibitior - 0.9748 97.48%
P-glycoprotein substrate - 0.8023 80.23%
CYP3A4 substrate - 0.5411 54.11%
CYP2C9 substrate - 0.6108 61.08%
CYP2D6 substrate - 0.8260 82.60%
CYP3A4 inhibition - 0.9607 96.07%
CYP2C9 inhibition - 0.8515 85.15%
CYP2C19 inhibition - 0.8554 85.54%
CYP2D6 inhibition - 0.9679 96.79%
CYP1A2 inhibition - 0.5370 53.70%
CYP2C8 inhibition - 0.9328 93.28%
CYP inhibitory promiscuity - 0.9078 90.78%
UGT catelyzed + 0.8000 80.00%
Carcinogenicity (binary) - 0.8300 83.00%
Carcinogenicity (trinary) Non-required 0.5880 58.80%
Eye corrosion - 0.9908 99.08%
Eye irritation - 0.5582 55.82%
Skin irritation - 0.6790 67.90%
Skin corrosion - 0.9521 95.21%
Ames mutagenesis - 0.7700 77.00%
Human Ether-a-go-go-Related Gene inhibition - 0.7173 71.73%
Micronuclear + 0.6900 69.00%
Hepatotoxicity - 0.6271 62.71%
skin sensitisation - 0.8917 89.17%
Respiratory toxicity + 0.5667 56.67%
Reproductive toxicity + 0.7778 77.78%
Mitochondrial toxicity - 0.5125 51.25%
Nephrotoxicity - 0.8749 87.49%
Acute Oral Toxicity (c) III 0.4735 47.35%
Estrogen receptor binding - 0.7807 78.07%
Androgen receptor binding - 0.7071 70.71%
Thyroid receptor binding - 0.8214 82.14%
Glucocorticoid receptor binding - 0.6441 64.41%
Aromatase binding - 0.5792 57.92%
PPAR gamma - 0.5313 53.13%
Honey bee toxicity - 0.9640 96.40%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.7700 77.00%
Fish aquatic toxicity - 0.4874 48.74%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 95.70% 98.95%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.23% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 92.81% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.77% 95.56%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 90.01% 94.62%
CHEMBL1821 P08173 Muscarinic acetylcholine receptor M4 88.09% 94.08%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 81.93% 99.23%
CHEMBL216 P11229 Muscarinic acetylcholine receptor M1 81.82% 94.23%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 81.52% 85.14%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 80.96% 94.45%
CHEMBL5028 O14672 ADAM10 80.74% 97.50%
CHEMBL3830 Q2M2I8 Adaptor-associated kinase 80.52% 83.10%
CHEMBL2535 P11166 Glucose transporter 80.34% 98.75%

Cross-Links

Top
PubChem 12310810
NPASS NPC72935